Abu Dhabi has added a new layer to the rules governing artificial intelligence in medicine. The Department of Health (DoH), the emirate’s healthcare regulator, has introduced an AI Clinician Framework to guide how the technology is used in patient care.
The announcement continues the emirate’s push to be both an early adopter of medical AI and a rule-setter for how it is applied. The Department has not yet made every detail of the framework public in the material reviewed, so this report focuses on what is established and on the regulatory setting it enters.
Building on existing standards
The framework sits within a body of rules the regulator has been assembling. DoH’s Responsible Artificial Intelligence Standard applies to the Department and to all licensed healthcare entities in Abu Dhabi that develop, buy or deploy AI, including through research collaborations, and covers the entire lifecycle of a system. It is designed to ensure that AI is technically robust, socially responsible and continuously evaluated.
Earlier policy set out concrete expectations. The minimum requirements for AI tools in Abu Dhabi include certification by recognised international agencies, compliance with local regulations and auditable validation statements. Organisations that use AI must also have clear governance, set boundaries on access to patient information, carry out regular audits and report to the regulator.
A clinician-focused framework is a logical next step. Hospital rules for software are one thing, but the way a doctor, nurse or specialist relies on AI at the bedside raises different questions about accountability, training and judgement.
The questions such a framework must answer
Medical AI now helps read scans, flag deteriorating patients, summarise notes and suggest treatments. Regulators worldwide are asking how far clinicians can rely on these outputs. The main issues include:
- Accountability: who is responsible when an AI-assisted decision causes harm?
- Oversight: when must a human clinician review or override a recommendation?
- Competence: what training should staff have before using AI tools?
- Transparency: should patients be told when AI has played a part in their care?
- Data: how is patient information protected when it is used to train or run systems?
Abu Dhabi’s leaders have framed the approach as balancing innovation with safeguards. At a roundtable last year, the Department’s chairman, Mansoor Ibrahim Al Mansoori, said AI “is not tomorrow’s technology, it is today’s reality.” His undersecretary, Dr Noura Al Ghaithi, said Abu Dhabi was treating AI as its engine and policy as its platform, turning data into insight and insight into action.
Training and international partnerships
Policy is being backed by skills programmes. The Department launched the Global AI Healthcare Academy to give healthcare professionals worldwide the theoretical knowledge and hands-on training needed to implement AI effectively. It has also signed an agreement with the Harvard Medical School International Centre for Genetic Disease covering AI and genomics research, training in generative AI and large language models for medical practice, and the development of national frameworks and regulations for responsible use.
Those links suggest the clinician framework will be shaped by international practice as well as local needs, an approach consistent with Abu Dhabi’s ambition to be a global healthcare destination.
What it means for patients
For patients, the immediate impact is likely to be subtle. They may notice that doctors use AI tools more openly, or that consent forms and information leaflets mention the technology. The longer-term aim is a system in which patients can trust that any AI used in their treatment has been tested, is monitored and remains under the control of a qualified professional.
Clear rules should also help healthcare providers, who need certainty before investing in expensive systems. Developers, for their part, will have a defined path to approval in one of the region’s most active health markets.
What to watch
The key tests will be implementation and enforcement. Observers will look for details on audit requirements, incident reporting, the role of clinician sign-off and how the framework applies to private clinics as well as large hospitals. They will also watch how it interacts with federal data-protection rules.
Abu Dhabi has made clear that it wants to lead on responsible medical AI. Whether the new framework becomes a model for the wider region will depend on how workable it proves in everyday clinical practice.
Comments 1